Delivery Order SPE2DB22D2206-SPE2DB25FJN65
Award Date 8/21/25
Potential Completion Date 8/22/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,175.33 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, a critical antibiotic medication. This firm fixed-price, competitively awarded delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The pharmaceuticals will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations....
- The Defense Logistics Agency awarded a delivery order valued at $7,365.36 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, a broad-spectrum antibiotic used in military and federal healthcare settings. The award, issued on August 14, 2025, with completion targeted for August 15, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performance...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,464.22 firm-fixed-price contract is for the delivery of 1 gram vials of the antibiotic Meropenem in 0.9% sodium chloride solution. The contract has an ultimate completion date of July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of 4,563,697,433 units of the pharmaceutical drug meropenem, a 2 gram vial. The contract has a total potential value of $2,440.78 and a completion date of February 20, 2024. This delivery order contract is not...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,625.71, is for the supply of MEROPENEM-0.9% NACL 1 GRAM/50S, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $7,963.79 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The delivery order carries no set-aside designation...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,030.52 to AmerisourceBergen Drug Corp on August 5, 2025, with completion scheduled for August 6, 2025. This competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99 billion prime vendor agreement running through December 2026. The delivery order will be performed at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,269.70 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, for the supply of Ertapenem 1 gram vials. This competitively awarded, firm fixed-price contract has an ultimate completion date of July 22, 2025, and represents a small-value pharmaceutical procurement with no set-aside designation. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $43,377.81 to AmerisourceBergen Drug Corp on August 18, 2025, with completion expected by August 19, 2025. This firm fixed-price, competitively awarded delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion and extends through December 2026. The delivery order represents a child contract...
- The Defense Logistics Agency awarded a $1,573.71 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price contract, which carries no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical. The delivery order will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania....